In silico analysis of human metabolism: Reconstruction, contextualization and application of genome-scale models

Current Opinion in Systems Biology

Volumn 2, Issue , 2017, Pages 29-38

  Geng, Jun ^a   Nielsen, Jens ^a,b,c  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b Chalmers University of Technology   (Denmark)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Constraint based analysis; Drug development; Genome scale metabolic model; Human metabolism; Topological analysis

Indexed keywords

BIBLIOMETRICS; CELL INTERACTION; CIRCULATION; CLINICAL FEATURE; COMPUTER MODEL; CONCEPTUAL FRAMEWORK; DATA ANALYSIS; DATA BASE; DRUG MANUFACTURE; GENETIC MODEL; GENOME SCALE METABOLIC MODEL; GENOTYPE; HUMAN; HUMAN GENOME; INFORMATION PROCESSING; LIVER CELL CARCINOMA; METABOLISM; METABOLITE; METABOLOMICS; NONALCOHOLIC FATTY LIVER; PHENOTYPE; REVIEW; STOICHIOMETRY; TISSUE INTERACTION; TRANSCRIPTOMICS;

EID: 85041388327     PISSN: None     EISSN: 24523100     Source Type: Journal    
DOI: 10.1016/j.coisb.2017.01.001     Document Type: Review

References (79)

1. Rezzi S., Ramadan Z., Martin F.-P.J., Fay L.B., van Bladeren P., Lindon J.C., Nicholson J.K., Kochhar S. Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res 2007, 6:4469-4477.
2. Anstee Q.M., Targher G., Day C.P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013, 10:330-344.
3. Roberts C.K., Hevener A.L., Barnard R.J. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol 2013, 3:1-58.
4. Würtz P., Mäkinen V.-P., Soininen P., Kangas A.J., Tukiainen T., Kettunen J., Savolainen M.J., Tammelin T., Viikari J.S., Rönnemaa T., et al. Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 2012, 61:1372-1380.
5. Kalhan S.C., Guo L., Edmison J., Dasarathy S., McCullough A.J., Hanson R.W., Milburn M. Plasma metabolomic profile in non-alcoholic fatty liver disease. Metabolism 2011, 60:404-413.
6. Ayers D., Day P.J. Systems medicine: the application of systems biology approaches for modern medical research and drug development. Mol Biol Int 2015, 2015:8.
7. Baird L.G., Banken R., Eichler H.G., Kristensen F.B., Lee D.K., Lim J.C.W., Lim R., Longson C., Pezalla E., Salmonson T., et al. Accelerated access to innovative medicines for patients in need. Clin Pharmacol Ther 2014, 96:559-571.
8. Bordbar A., Palsson B.O. Using the reconstructed genome-scale human metabolic network to study physiology and pathology. J Intern Med 2012, 271:131-141.
9. Mardinoglu A., Nielsen J. Systems medicine and metabolic modelling. J Intern Med 2012, 271:142-154.
10. O'Brien Edward J., Monk Jonathan M., Palsson Bernhard O. Using genome-scale models to predict biological capabilities. Cell 2015, 161:971-987.
11. Ryu J.Y., Kim H.U., Lee S.Y. Reconstruction of genome-scale human metabolic models using omics data. Integr Biol 2015, 7:859-868.
12. Duarte N.C., Becker S.A., Jamshidi N., Thiele I., Mo M.L., Vo T.D., Srivas R., Palsson B.Ø. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci 2007, 104:1777-1782.
13. Ma H., Sorokin A., Mazein A., Selkov A., Selkov E., Demin O., Goryanin I. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 2007, 3:135.
14. Agren R., Bordel S., Mardinoglu A., Pornputtapong N., Nookaew I., Nielsen J. Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput Biol 2012, 8:e1002518.
15. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38:D355-D360.
16. Romero P., Wagg J., Green M.L., Kaiser D., Krummenacker M., Karp P.D. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 2005, 6:R2.
17. Mardinoglu A., Agren R., Kampf C., Asplund A., Uhlen M., Nielsen J. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat Commun 2014, 5.
18. Mardinoglu A., Agren R., Kampf C., Asplund A., Nookaew I., Jacobson P., Walley A.J., Froguel P., Carlsson L.M., Uhlen M., et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol Syst Biol 2013, 9:649.
19. Fahy E., Subramaniam S., Murphy R.C., Nishijima M., Raetz C.R.H., Shimizu T., Spener F., van Meer G., Wakelam M.J.O., Dennis E.A. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 2009, 50:S9-S14.
20. Gille C., Bölling C., Hoppe A., Bulik S., Hoffmann S., Hübner K., Karlstädt A., Ganeshan R., König M., Rother K., et al. HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol Syst Biol 2010, 6:411.
21. Thiele I., Swainston N., Fleming R.M.T., Hoppe A., Sahoo S., Aurich M.K., Haraldsdottir H., Mo M.L., Rolfsson O., Stobbe M.D., et al. A community-driven global reconstruction of human metabolism. Nat Biotech 2013, 31:419-425.
22. Sahoo S., Thiele I. Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells. Hum Mol Genet 2013, 22:2705-2722.
23. Swainston N., Smallbone K., Hefzi H., Dobson P.D., Brewer J., Hanscho M., Zielinski D.C., Ang K.S., Gardiner N.J., Gutierrez J.M., et al. Recon 2.2: from reconstruction to model of human metabolism. Metabolomics 2016, 12:1-7.
24. Lewis N.E., Schramm G., Bordbar A., Schellenberger J., Andersen M.P., Cheng J.K., Patel N., Yee A., Lewis R.A., Eils R., et al. Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nat Biotech 2010, 28:1279-1285.
25. Shlomi T., Cabili M.N., Ruppin E. Predicting metabolic biomarkers of human inborn errors of metabolism. Mol Syst Biol 2009, 5:263.
26. Keen J.C., Moore H.M. The genotype-tissue expression (GTEx) project: linking clinical data with molecular analysis to advance personalized medicine. J Pers Med 2015, 5:22-29.
27. Petryszak R., Keays M., Tang Y.A., Fonseca N.A., Barrera E., Burdett T., Füllgrabe A., Fuentes A.M.-P., Jupp S., Koskinen S., et al. Expression Atlas update-an integrated database of gene and protein expression in humans, animals and plants. Nucleic Acids Res 2016, 44:D746-D752.
28. Barrett T., Wilhite S.E., Ledoux P., Evangelista C., Kim I.F., Tomashevsky M., Marshall K.A., Phillippy K.H., Sherman P.M., Holko M., et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2013, 41:D991-D995.
29. Uhlén M., Fagerberg L., Hallström B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson Å., Kampf C., Sjöstedt E., Asplund A., et al. Tissue-based map of the human proteome. Science 2015, 347.
30. Machado D., Herrgård M. Systematic evaluation of methods for integration of transcriptomic data into constraint-based models of metabolism. PLoS Comput Biol 2014, 10:e1003580.
31. Becker S.A., Palsson B.O. Context-specific metabolic networks are consistent with experiments. PLoS Comput Biol 2008, 4:e1000082.
32. Bordbar A., Lewis N.E., Schellenberger J., Palsson B.Ø., Jamshidi N. Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol Syst Biol 2010, 6:422.
33. Chang R.L., Xie L., Xie L., Bourne P.E., Palsson B.Ø. Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput Biol 2010, 6:e1000938.
34. Zur H., Ruppin E., Shlomi T. iMAT: an integrative metabolic analysis tool. Bioinformatics 2010, 26:3140-3142.
35. Jerby L., Shlomi T., Ruppin E. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol Syst Biol 2010, 6:401.
36. Zhao Y., Huang J. Reconstruction and analysis of human heart-specific metabolic network based on transcriptome and proteome data. Biochem Biophys Res Commun 2011, 415:450-454.
37. Wang Y., Eddy J.A., Price N.D. Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst Biol 2012, 6:1-16.
38. Vlassis N., Pacheco M.P., Sauter T. Fast reconstruction of compact context-specific metabolic network models. PLoS Comput Biol 2014, 10:e1003424.
39. Uhlén M., Fagerberg L., Hallström B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson Å., Kampf C., Sjöstedt E., Asplund A., et al. Tissue-based map of the human proteome. Science 2015, 347. 10.1126/science.1260419.
40. Agren R., Mardinoglu A., Asplund A., Kampf C., Uhlen M., Nielsen J. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol Syst Biol 2014, 10:721.
41. Väremo L., Scheele C., Broholm C., Mardinoglu A., Kampf C., Asplund A., Nookaew I., Uhlén M., Pedersen Bente K., Nielsen J. Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. Cell Rep 2015, 11:921-933.
42. Yizhak K., Gaude E., Le Dévédec S., Waldman Y.Y., Stein G.Y., van de Water B., Frezza C., Ruppin E. Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer. eLife 2014, 3:e03641.
43. Schultz A., Qutub A.A. Reconstruction of tissue-specific metabolic networks using CORDA. PLoS Comput Biol 2016, 12:e1004808.
44. Satish Kumar V., Dasika M.S., Maranas C.D. Optimization based automated curation of metabolic reconstructions. BMC Bioinformatics 2007, 8:212.
45. Thiele I., Vlassis N., Fleming R.M.T. fastGapFill: efficient gap filling in metabolic networks. Bioinformatics 2014, 30:2529-2531.
46. Horton P., Park K.-J., Obayashi T., Fujita N., Harada H., Adams-Collier C.J., Nakai K. WoLF PSORT: protein localization predictor. Nucleic Acids Res 2007, 35:W585-W587.
47. Yu C.-S., Chen Y.-C., Lu C.-H., Hwang J.-K. Prediction of protein subcellular localization. Proteins 2006, 64:643-651.
48. Seo S., Lewin H.A. Reconstruction of metabolic pathways for the cattle genome. BMC Syst Biol 2009, 3:33.
49. Selvarasu S., Karimi I.A., Ghim G.-H., Lee D.-Y. Genome-scale modeling and in silico analysis of mouse cell metabolic network. Mol Biosyst 2009, 6:152-161.
50. Yizhak K., Chaneton B., Gottlieb E., Ruppin E. Modeling cancer metabolism on a genome scale. Mol Syst Biol 2015, 11:817.
51. Folger O., Jerby L., Frezza C., Gottlieb E., Ruppin E., Shlomi T. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 2011, 7:501.
52. Jerby L., Wolf L., Denkert C., Stein G.Y., Hilvo M., Oresic M., Geiger T., Ruppin E. Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res 2012, 72:5712-5720.
53. Wu M., Chan C. Prediction of therapeutic microRNA based on the human metabolic network. Bioinformatics 2014, 30:1163-1171.
54. Asgari Y., Salehzadeh-Yazdi A., Schreiber F., Masoudi-Nejad A. Controllability in cancer metabolic networks according to drug targets as driver nodes. PLoS One 2013, 8:e79397.
55. Yizhak K., Le Dévédec S.E., Rogkoti V.M., Baenke F., de Boer V.C., Frezza C., Schulze A., van de Water B., Ruppin E. A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol Syst Biol 2014, 10:744.
56. Kotze H.L., Armitage E.G., Sharkey K.J., Allwood J.W., Dunn W.B., Williams K.J., Goodacre R. A novel untargeted metabolomics correlation-based network analysis incorporating human metabolic reconstructions. BMC Syst Biol 2013, 7:107.
57. Marusyk A., Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 2010, 1805:105.
58. Uhlén M., Björling E., Agaton C., Szigyarto C.A.-K., Amini B., Andersen E., Andersson A.-C., Angelidou P., Asplund A., Asplund C., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4:1920-1932.
59. Bordbar A., McCloskey D., Zielinski Daniel C., Sonnenschein N., Jamshidi N., Palsson Bernhard O. Personalized whole-cell kinetic models of metabolism for discovery in genomics and pharmacodynamics. Cell Syst 2015, 1:283-292.
60. Patil K.R., Nielsen J. Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc Natl Acad Sci U S A 2005, 102:2685-2689.
61. Fromenty B., Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995, 67:101-154.
62. Mensenkamp A.R., Havekes L.M., Romijn J.A., Kuipers F. Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E. J Hepatol 2001, 35:816-822.
63. Deo R.C., Hunter L., Lewis G.D., Pare G., Vasan R.S., Chasman D., Wang T.J., Gerszten R.E., Roth F.P. Interpreting metabolomic profiles using unbiased pathway models. PLoS Comput Biol 2010, 6:e1000692.
64. Morine M.J., Tierney A.C., van Ommen B., Daniel H., Toomey S., Gjelstad I.M.F., Gormley I.C., Pérez-Martinez P., Drevon C.A., López-Miranda J., et al. Transcriptomic coordination in the human metabolic network reveals links between n-3 fat intake, adipose tissue gene expression and metabolic health. PLoS Comput Biol 2011, 7:e1002223.
65. Capel F., Klimčáková E., Viguerie N., Roussel B., Vítková M., Kováčiková M., Polák J., Kováčová Z., Galitzky J., Maoret J.-J., et al. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes 2009, 58:1558-1567.
66. Zelezniak A., Pers T.H., Soares S., Patti M.E., Patil K.R. Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS Comput Biol 2010, 6:e1000729.
67. Orth J.D., Thiele I., Palsson B.O. What is flux balance analysis?. Nat Biotech 2010, 28:245-248.
68. Shlomi T., Benyamini T., Gottlieb E., Sharan R., Ruppin E. Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the warburg effect. PLoS Comput Biol 2011, 7:e1002018.
69. Bordel S., Agren R., Nielsen J. Sampling the solution space in genome-scale metabolic networks reveals transcriptional regulation in key enzymes. PLoS Comput Biol 2010, 6:e1000859.
70. Gatto F., Miess H., Schulze A., Nielsen J. Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism. Sci Rep 2015, 5:10738.
71. Megchelenbrink W., Katzir R., Lu X., Ruppin E., Notebaart R.A. Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival. Proc Natl Acad Sci U S A 2015, 112:12217-12222.
72. Brunk E., Mih N., Monk J., Zhang Z., O'Brien E.J., Bliven S.E., Chen K., Chang R.L., Bourne P.E., Palsson B.O. Systems biology of the structural proteome. BMC Syst Biol 2016, 10:26.
73. Zhang Y., Thiele I., Weekes D., Li Z., Jaroszewski L., Ginalski K., Deacon A.M., Wooley J., Lesley S.A., Wilson I.A., et al. Three-dimensional structural view of the central metabolic network of Thermotoga maritima. Science 2009, 325:1544-1549.
74. Mih N., Brunk E., Bordbar A., Palsson B.O. A multi-scale computational platform to mechanistically assess the effect of genetic variation on drug responses in human erythrocyte metabolism. PLoS Comput Biol 2016, 12:e1005039.
75. Thiele I., Jamshidi N., Fleming R.M.T., Palsson B.Ø. Genome-scale reconstruction of Escherichia coli's transcriptional and translational machinery: a knowledge base, its mathematical formulation, and its functional characterization. PLoS Comput Biol 2009, 5:e1000312.
76. O'Brien E.J., Lerman J.A., Chang R.L., Hyduke D.R., Palsson B.Ø. Genome-scale models of metabolism and gene expression extend and refine growth phenotype prediction. Mol Syst Biol 2013, 9:693.
77. Karr Jonathan R., Sanghvi Jayodita C., Macklin Derek N., Gutschow Miriam V., Jacobs Jared M., Bolival B., Assad-Garcia N., Glass John I., Covert Markus W. A whole-cell computational model predicts phenotype from genotype. Cell 2012, 150:389-401.
78. Bordbar A., Feist A.M., Usaite-Black R., Woodcock J., Palsson B.O., Famili I. A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst Biol 2011, 5:1-17.
79. Krauss M., Schaller S., Borchers S., Findeisen R., Lippert J., Kuepfer L. Integrating cellular metabolism into a multiscale whole-body model. PLoS Comput Biol 2012, 8:e1002750.